Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 14,560
-2,430 (-14.30%)
At close: Oct 2, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 33.59 billion as of October 2, 2026. Its market cap has decreased by -11.11% in one year.
Market Cap
33.59B
Enterprise Value
n/a
Revenue
449.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
14,560.00
ChartMarket Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 33.59B, a decrease of -42.67%. That is a compound annual growth rate of -16.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 33.59B | -2.93% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Psomagen | 57.32B |
| ADBiotech | 55.38B |
| J2KBIO | 52.92B |
| Quratis | 44.92B |
| Parataxis Korea | 44.13B |
| HLB Pep | 42.94B |
| Progen | 35.67B |
| Kainos Medicine | 35.56B |